A Phase I Study of LP-108 in Patients With Relapsed or Refractory B-cell Lymphoma
Clinical trial NCT04356846 · UNKNOWN
Trial details
- NCT number
- NCT04356846
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-01
- Primary completion
- 2023-12-01
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.